Roberto Musneci, from GSK to A&D Pharma
Roberto Musneci, the Italian who ran the biggest player on the Romanian drug market, GlaxoSmithKline (GSK), between 2001-2006 and who has recently accepted a non-executive position at A&D Pharma, speaks about the advantages the entrepreneur status brings in an interview with ZF
Roberto Musneci, the Italian who ran the biggest player on the Romanian drug market, GlaxoSmithKline (GSK), between 2001-2006 and who has recently accepted a non-executive position at A&D Pharma, speaks about the advantages the entrepreneur status brings in an interview with ZF.
From the position he held at GSK, Musneci coordinated activities in 13 countries, namely an area that brought the British group 400m-euro turnover and included 1,600 employees.
He gave up a comfortable seat in one of the world’s biggest pharmaceutical companies and entered the world of consulting services to pursue institutional communication.
Recently, however, Musneci has added a new position to his CV; that of a non-executive manager at A&D Pharma, the market leader on the distribution and retail segment. “(…) As a rule, a non-executive manager’s task is to control minority shareholders’ interests from the outside and independently. It’s an important position because you guarantee for those shareholders who are not directly involved in the company,” says Musneci.
Though he has had offers to continue to work with a multinational, Musneci says he is not tempted to go back to management, preferring the entrepreneur status. “Though I had a very good position, it was not my personal investment. Firstly, I wanted to make this shift from management to entrepreneurship and secondly I’ve seen Romania, amid growth registered in recent years, can offer plenty of opportunities in the field of consulting services,” says Musneci. On the other hand, work in a multinational has changed a lot in recent years.
The mandate in Romania allowed him to meet his current business partner, Alex Serban, together with whom he holds Serban & Musneci Associates company. According to Finance Ministry data, the firm last year generated 0.4m-euro turnover and net income of almost 30,000 euros. The firm’s customers have included Vodafone, Lafarge, Danone, Rompetrol, Nokia, GSK, A&D Pharma.
In addition to growth opportunities Musneci says, “Romania has a still weak economic structure. The fact that the market is not as developed as others offers a kind of shelter”. In the past two years, the team of Serban & Musneci Associates has grown from 4-5 people to 20 people. And Musneci says the development of this business remains his priority.
-
Urmează sărbători bogate pentru retailul alimentar: „Românii renunță la multe cheltuieli discreționare și se orientează mai mult către consumul acasă. Industria de FMCG este una dintre cele mai reziliente în perioadele dificile financiar“. Analiștii companiei de cercetare de piață NielsenIQ vorbesc despre un „optimism prudent“ în T4 2026Eveniment · 13 noiembrie 2026
-
Analiză ZF. Cum arată piața untului față de acum cinci ani: jucătorii au avut încasări mai mari cu 23%, dar volume sub nivelul din 2020. Grupul francez Lactalis deține 53% din vânzările de unt din retail, de peste cinci ori mai mult decât următorul jucătorRetail&Agrobusiness · 13 noiembrie 2026
-
Silvia Axinescu, counsel, Reff & Asociații | Deloitte Legal: Pentru companiile care folosesc agenți AI, riscul unei amenzi pe AI Act este deocamdată aproape zero, pentru că România nu are încă o autoritate desemnată formal, dar ele răspund deja față de persoanele prejudiciate de un agentBusiness Hi-Tech · 13 noiembrie 2026